Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses - PubMed (original) (raw)

Review

Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses

Bharat B Aggarwal et al. Molecules. 2014.

Abstract

Curcumin (diferuloylmethane), a golden pigment from turmeric, has been linked with antioxidant, anti-inflammatory, anticancer, antiviral, antibacterial, and antidiabetic properties. Most of the these activities have been assigned to methoxy, hydroxyl, α,β-unsaturated carbonyl moiety or to diketone groups present in curcumin. One of the major metabolites of curcumin is tetrahydrocurcumin (THC), which lacks α,β-unsaturated carbonyl moiety and is white in color. Whether THC is superior to curcumin on a molecular level is unclear and thus is the focus of this review. Various studies suggest that curcumin is a more potent antioxidant than THC; curcumin (but not THC) can bind and inhibit numerous targets including DNA (cytosine-5)-methyltransferase-1, heme oxygenase-1, Nrf2, β-catenin, cyclooxygenase-2, NF-kappaB, inducible nitric oxide synthase, nitric oxide, amyloid plaques, reactive oxygen species, vascular endothelial growth factor, cyclin D1, glutathione, P300/CBP, 5-lipoxygenase, cytosolic phospholipase A2, prostaglandin E2, inhibitor of NF-kappaB kinase-1, -2, P38MAPK, p-Tau, tumor necrosis factor-α, forkhead box O3a, CRAC; curcumin can inhibit tumor cell growth and suppress cellular entry of viruses such as influenza A virus and hepatitis C virus much more effectively than THC; curcumin affects membrane mobility; and curcumin is also more effective than THC in suppressing phorbol-ester-induced tumor promotion. Other studies, however, suggest that THC is superior to curcumin for induction of GSH peroxidase, glutathione-S-transferase, NADPH: quinone reductase, and quenching of free radicals. Most studies have indicated that THC exhibits higher antioxidant activity, but curcumin exhibits both pro-oxidant and antioxidant properties.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1

Figure 1

With increasing pH (alkalinity), curcumin changes to red. Curcumin metabolically converts to tetrahydrocurcumin by using the NADPH-dependent curcumin/dihydrocurcumin reductase (CurA) enzyme. Structurally, curcumin has the α,β-unsaturated carbonyl group, but tetrahydrocurcumin lacks α,β dienes.

Figure 2

Figure 2

Molecular targets of curcumin vs tetrahydrocurcumin. Curcumin is more effective in modulating some targets, but tetrahydrocurcumin is more effective in others. Some molecules are modulated only by curcumin and not by tetrahydrocurcumin.

Similar articles

Cited by

References

    1. Prasad S., Gupta S.C., Tyagi A.K., Aggarwal B.B. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol. Adv. 2014;32:1053–1064. doi: 10.1016/j.biotechadv.2014.04.004. - DOI - PubMed
    1. Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Curcumin: the Indian solid gold. In: Aggarwal B.B., Surh Y.J., Shishodia S., editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer; New York, NY, USA: 2007. pp. 1–75. Advances in Experimental Medicine and Biology, Series Volume 595. - PubMed
    1. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–398. - PubMed
    1. Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Ann. Rev. Nutr. 2010;30:173–199. doi: 10.1146/annurev.nutr.012809.104755. - DOI - PMC - PubMed
    1. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol. Sci. 2009;30:85–94. doi: 10.1016/j.tips.2008.11.002. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources